EuroscreenFast has been a pioneer in GPCR science for more than 30 years with a catalogue that includes over 1,000 functional assays representing more than 530 GPCR and other targets including ion channels, kinases and other enzymes. Therapeutic developers worldwide trust EuroscreenFast with their compounds to determine affinity, potency, efficacy and functional selectivity.
Beyond binding & functional GPCR screening, EuroscreenFast also boasts an impressive deorphanisation track record thanks to a world leading platform based on a unique collection of tissue extracts, cellular tools and one of the largest libraries of verified orphan GPCR cell lines.
Custom cell line and assay development is also core to the offering. Using a proprietary high-copy, bicistronic expression vector, cell lines from a range of species are engineered to express our client’s target of choice and validated for use in functional or binding assays, or as a screening tool for drug discovery. EuroscreenFast has also developed specialized assays to bridge the gap between in vitro and in vivo data.
The team of highly skilled and expert scientists strategically design each program based on the latest knowledge of the target’s biology – EuroscreenFast is your unrivalled GPCR development partner.
EuroscreenFast is a business unit of EPICS Therapeutics SA.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
2-10 employees
-
Headquarters
-
Gosselies
-
Type
-
Privately Held
-
Founded
-
1994
-
Specialties
-
GPCR, Screening, Cell based assays, Assay development, Deorphanizaton, Cell Line Development, and Cell-based assays
